WATERTOWN, Mass., April 16, 2024 (GLOBE NEWSWIRE) -- Eloxx Pharmaceuticals, Inc. (OTC: ELOX), a leader in ribosomal RNA-targeted genetic therapies for rare diseases, today provided program updates for ...
Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Electronic Liquidity Exchange (ELX), a new US futures exchange backed by a group of banks, dealers and ...
ELX-02 treatment improved podocyte foot process effacement in all three patients by an average of 60% based on a blinded kidney biopsy analysis by NIPOKA GmbH Biopsy results support clinical benefit ...
WATERTOWN, Mass., Sept. 14, 2022 (GLOBE NEWSWIRE) -- Eloxx Pharmaceuticals, Inc. (NASDAQ: ELOX), a leader in ribosomal RNA-targeted genetic therapies for rare diseases, today announced topline results ...
NEW YORK, July 10 (Reuters) - U.S. futures exchange ELX Futures LP launches on Friday, challenging derivatives giant CME Group Inc with the backing of its bank owners and an introductory offer of free ...
CHICAGO (Reuters) - The Wall Street powerhouses that founded ELX Futures LP to combat CME Group Inc 's virtual monopoly in Treasury futures are cutting their ownership stakes in the tiny exchange, ...
WATERTOWN, Mass., Sept. 07, 2023 (GLOBE NEWSWIRE) -- Eloxx Pharmaceuticals, Inc. (NASDAQ: ELOX), a leader in ribosomal RNA-targeted genetic therapies for rare diseases, today provided an update on the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results